Following the Genetic Breadcrumbs of MPNs
We provide an overview of a recent study in Cancer Discovery by Leongamornlert and colleagues involving genomic profiling of 30 patients with myeloproliferative neoplasms using available blood or bone marrow samples to assess what factors underlie disease evolution or predict stability. See related article by Leongamornlert et al., p. 1843.
Authors
- Vijay G. Sankaran (ORCID: https://orcid.org/0000-0003-0044-443X)
- Gaurav Agarwal (ORCID: https://orcid.org/0000-0002-6710-8652)
Institutions
- Broad Institute (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Dana-Farber Cancer Institute (US)
- Harvard Stem Cell Institute (US)
Publication Details
- Journal
- Cancer Discovery
- Published
- 2026-09-01
- DOI
- https://doi.org/10.1158/2159-8290.cd-26-1265
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00